Secondary prevention of heart disease and cardiovascular disease principally involves mitigating risk among individuals considered to be at high risk for serious adverse events that include stroke ...

The US Preventive Services Task Force recommends against adults 60 and older starting on low-dose aspirin for the primary prevention of cardiovascular disease, and for people ages 40 to 59 who ...

In 2007–2008, antiplatelet medications were prescribed at only 46.9% of visits for patients with ischemic vascular disease. ... Aspirin in the Secondary Prevention of Cardiovascular Disease.

Risk factors in adults with cardiovascular disease are worsening over time despite advances in secondary prevention, study shows. ScienceDaily . Retrieved June 2, 2025 from www.sciencedaily.com ...

As the population ages and patients with heart disease survive longer, a growing pool of patients could benefit from secondary prevention of heart disease. Secondary prevention includes lifestyle ...

Low-dose aspirin is among the most widely used agents for the prevention of cardiovascular disease. 4-8 Its efficacy has been established in secondary prevention trials, in which the benefits ...

Despite the abundant evidence base for the secondary prevention of coronary artery disease, 1 many of these therapies are underused in clinical practice. 1 – 4 These gaps between evidence and clinical ...

Secondary prevention of ischemic heart disease could have a huge impact on the global epidemic of cardiovascular disease. Here Ginés Sanz and Valentin Fuster consider the value of a 'polypill ...

Secondary prevention medications for cardiovascular diseases (CVD) are underused globally and additional strategies to ...

SAN FRANCISCO — High-sensitivity cardiac troponin-T (hs-cTnT) levels in outpatients with stable coronary heart disease are independently associated with an increased risk of secondary ...

Cardiovascular disease remains a leading cause of death worldwide, and managing it effectively requires more than just ...